Ruyuan He

1.5k total citations · 1 hit paper
29 papers, 995 citations indexed

About

Ruyuan He is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Ruyuan He has authored 29 papers receiving a total of 995 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 7 papers in Epidemiology. Recurrent topics in Ruyuan He's work include Inflammasome and immune disorders (5 papers), Ferroptosis and cancer prognosis (4 papers) and interferon and immune responses (3 papers). Ruyuan He is often cited by papers focused on Inflammasome and immune disorders (5 papers), Ferroptosis and cancer prognosis (4 papers) and interferon and immune responses (3 papers). Ruyuan He collaborates with scholars based in China and United States. Ruyuan He's co-authors include Qing Geng, Wenyang Jiang, Bohao Liu, Weichen Lin, Heng Meng, Ning Li, Bo Hao, Zilong Lu, Rui Xiong and Tao Fan and has published in prestigious journals such as Life Sciences, Ecotoxicology and Environmental Safety and Frontiers in Pharmacology.

In The Last Decade

Ruyuan He

28 papers receiving 989 citations

Hit Papers

Itaconate inhibits ferroptosis of macrophage via Nrf2 pat... 2022 2026 2023 2024 2022 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Itaconate inhibits ferroptosis of macrophage via Nrf2 pathways against sepsis-induced acute lung injury
    2022 177 citations Ruyuan He, Bohao Liu et al. Cell Death Discovery profile →

Peers

Ruyuan He
Hong Peng China
Jing Cao China
Sisi Chen China
Hua Jiang China
Paul B. Comish United States
Zhihui Wang China
Rami M. Elshazli Egypt
Yu Hu China
Weichen Lin China
Vindi Jurinović Germany
Hong Peng China
Ruyuan He
Citations per year, relative to Ruyuan He Ruyuan He (= 1×) peers Hong Peng

Countries citing papers authored by Ruyuan He

Since Specialization
Citations

This map shows the geographic impact of Ruyuan He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruyuan He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruyuan He more than expected).

Fields of papers citing papers by Ruyuan He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruyuan He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruyuan He. The network helps show where Ruyuan He may publish in the future.

Co-authorship network of co-authors of Ruyuan He

This figure shows the co-authorship network connecting the top 25 collaborators of Ruyuan He. A scholar is included among the top collaborators of Ruyuan He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruyuan He. Ruyuan He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Jiang, Zewen, et al.. (2025). Fumarate Hydratase Restrains mtDNA Attenuates LPS-Induced Acute Lung Injury Through cGAS-STING Pathways. Journal of Inflammation Research. Volume 18. 5399–5413.
3.
He, Ruyuan, Ke Yi, Bohao Liu, et al.. (2024). The role and therapeutic potential of itaconate in lung disease. Cellular & Molecular Biology Letters. 29(1). 129–129. 2 indexed citations
4.
Zhang, Tianyu, et al.. (2024). Primary squamous cell carcinoma and adenocarcinoma simultaneously occurring in the same lung lobe: a case report and literature review. Frontiers in Oncology. 14. 1402297–1402297. 1 indexed citations
5.
Li, Guorui, Donghang Li, Ruyuan He, et al.. (2024). Mangiferin alleviates diabetic pulmonary fibrosis in mice via inhibiting endothelial-mesenchymal transition through AMPK/FoxO3/SIRT3 axis. Acta Pharmacologica Sinica. 45(5). 1002–1018. 14 indexed citations
6.
Li, Boyang, et al.. (2024). Novel insights and new therapeutic potentials for macrophages in pulmonary hypertension. Respiratory Research. 25(1). 147–147. 4 indexed citations
7.
Li, Guorui, Wei Wang, Rui Xiong, et al.. (2023). Pretreatment with Kahweol Attenuates Sepsis‐Induced Acute Lung Injury via Improving Mitochondrial Homeostasis in a CaMKKII/AMPK‐Dependent Pathway. Molecular Nutrition & Food Research. 67(19). e2300083–e2300083. 10 indexed citations
8.
Jiang, Wenyang, Jie Ren, Hongling Zhou, et al.. (2023). TMEM16A deficiency in alveolar type 2 epithelial cells protected against endoplasmic reticulum stress-induced ferroptosis during acute lung injury. International Immunopharmacology. 125(Pt B). 111208–111208. 8 indexed citations
9.
He, Ruyuan, et al.. (2023). The role of HDAC3 and its inhibitors in regulation of oxidative stress and chronic diseases. Cell Death Discovery. 9(1). 39 indexed citations
10.
Fu, Xiaoyu, Ping Li, Qi Zhou, et al.. (2023). Mechanism of PARP inhibitor resistance and potential overcoming strategies. Genes & Diseases. 11(1). 306–320. 36 indexed citations
11.
Hao, Bo, Zilong Lu, Juan Xiong, et al.. (2022). Single-cell RNA sequencing analysis revealed cellular and molecular immune profiles in lung squamous cell carcinoma. Translational Oncology. 27. 101568–101568. 18 indexed citations
12.
Xiong, Rui, Ning Li, Bohao Liu, et al.. (2022). Oral Hydroxychloroquine Mitigates Lipopolysaccharide-induced LungInjury by Inhibiting Pyroptosis in Mice. Current Molecular Pharmacology. 16(3). 362–373. 2 indexed citations
13.
Xiong, Rui, Ruyuan He, Bohao Liu, et al.. (2021). Ferroptosis: A New Promising Target for Lung Cancer Therapy. Oxidative Medicine and Cellular Longevity. 2021(1). 8457521–8457521. 43 indexed citations
14.
Li, Ning, Rui Xiong, Ruyuan He, et al.. (2021). Mangiferin Mitigates Lipopolysaccharide-Induced Lung Injury by Inhibiting NLRP3 Inflammasome Activation. Journal of Inflammation Research. Volume 14. 2289–2300. 26 indexed citations
15.
Xiong, Rui, Wenyang Jiang, Ning Li, et al.. (2021). PM2.5-induced lung injury is attenuated in macrophage-specific NLRP3 deficient mice. Ecotoxicology and Environmental Safety. 221. 112433–112433. 60 indexed citations
16.
Liu, Bohao, Ruyuan He, Lin Zhang, et al.. (2021). Inflammatory Caspases Drive Pyroptosis in Acute Lung Injury. Frontiers in Pharmacology. 12. 631256–631256. 74 indexed citations
17.
He, Ruyuan, Zilong Lu, Lin Zhang, et al.. (2020). The clinical course and its correlated immune status in COVID-19 pneumonia. Journal of Clinical Virology. 127. 104361–104361. 170 indexed citations
18.
Meng, Heng, Rui Xiong, Ruyuan He, et al.. (2020). CT imaging and clinical course of asymptomatic cases with COVID-19 pneumonia at admission in Wuhan, China. Journal of Infection. 81(1). e33–e39. 182 indexed citations
19.
Li, Donghang, Ruyuan He, Guoqiang Hou, et al.. (2020). Characterization of the Esophageal Microbiota and Prediction of the Metabolic Pathways Involved in Esophageal Cancer. Frontiers in Cellular and Infection Microbiology. 10. 268–268. 44 indexed citations
20.
Fan, Tao, Bo Hao, Bo Shen, et al.. (2020). Nomogram for Predicting COVID-19 Disease Progression Based on Single-Center Data: Observational Study and Model Development. JMIR Medical Informatics. 8(9). e19588–e19588. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hong Peng Breakdown of academic impact, for papers by Jing Cao Breakdown of academic impact, for papers by Sisi Chen Breakdown of academic impact, for papers by Hua Jiang Breakdown of academic impact, for papers by Paul B. Comish Breakdown of academic impact, for papers by Zhihui Wang Breakdown of academic impact, for papers by Rami M. Elshazli Breakdown of academic impact, for papers by Yu Hu Breakdown of academic impact, for papers by Weichen Lin Breakdown of academic impact, for papers by Vindi Jurinović
Rankless by CCL
2026